Aposense

  • Home
  • About Us
    • Our mission and vision
    • Scientific president
    • Team
    • Board of directors
    • Scientific advisory board
    • Intellectual property
  • Our Technology
  • Our Platform
  • Investors
    • Presentations
    • Financial Reports
    • Stock Information
  • News Room
    • Press release
    • Publications
  • Other Projects
    • ATT-11T: Anti cancer pro-drug
    • ML-10
  • Contact Us


Stock Information

Aposense

Contact Us

Telephone: + 972.73.239.7600
Fax: +972.3.921.57.14
E-mail: info@aposense.com

Careers

Latest news

  • Notice: Convening of a Shareholders Meeting

    29 May 2019

  • Aposense has signed a definitive agreement with SirVir Ltd. A private company, jointly owned by Aposense, Prof. Roger D. Kornberg, and Access Industries Holdings LLC. SirVir will engage in the development and commercialization of products in the field of treatment of respiratory viral infections, based on the Apo-Si technology developed by the Company

    8 Jan 2019

  • Notice: Convening of a Shareholders Meeting

    17 Sep 2018

Aposense © 2020. Privacy Policy
  • Home
  • About Us
    ▼
    • Our mission and vision
    • Scientific president
    • Team
    • Board of directors
    • Scientific advisory board
    • Intellectual property
  • Our Technology
  • Our Platform
  • Investors
    ▼
    • Presentations
    • Financial Reports
    • Stock Information
  • News Room
    ▼
    • Press release
    • Publications
  • Other Projects
    ▼
    • ATT-11T: Anti cancer pro-drug
    • ML-10
  • Contact Us
Skip to content
Open toolbar

Accessibility Tools

  • Increase Text
  • Decrease Text
  • Grayscale
  • High Contrast
  • Negative Contrast
  • Light Background
  • Links Underline
  • Readable Font
  • Reset